Newer Treatments for Mood and Anxiety Disorders.
The Medical clinics of North America September 1, 2024 Jesse Markman, Heidi Combs 5 citations
For more than 20 years, the mainstay of pharmacologic treatment for depression and anxiety disorders has been serotonin reuptake inhibitors and selective serotonin and norepinephrine reuptake inhibitors. There are newer medications, many with novel mechanisms of action, that have come to market; however, first-line treatments remain the same. There are now more robust data on the use of various...